We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.
- Authors
Niitsu, N; Okamoto, M; Tamaru, J-I; Yoshino, T; Nakamura, N; Nakamura, S; Ohshima, K; Nakamine, H; Hirano, M
- Abstract
CD5-positive (CD5+) diffuse large B-cell lymphoma (DLBCL) comprises ∼10% of DLBCLs, and it is associated with poor prognosis. The clinicopathologic characteristics and prognosis of CD5-negative (CD5-) DLBCL and CD5+ DLBCL were compared.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 10, p2069
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdq057